102879-42-5 Usage
General Description
2-(2-Aminoethyl)benzoic acid hydrochloride, also known as (2-aminoethyl)benzoic acid, is a chemical compound which falls under the classification of organic compound. It is composed of an aromatic benzene ring accompanied by an aminoethyl group and a carboxylic acid group. These structural features allow the compound to act as an acid, amine, and also benzene molecule. As a hydrochloric salt, it often presents as a white crystalline powder. The compound bears the molecular formula C9H12ClNO2 and has applications in the fields of pharmaceutical research and biochemistry. However, it is advised to handle this chemical with care as it may cause eye, skin and respiratory irritation.
Check Digit Verification of cas no
The CAS Registry Mumber 102879-42-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,2,8,7 and 9 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 102879-42:
(8*1)+(7*0)+(6*2)+(5*8)+(4*7)+(3*9)+(2*4)+(1*2)=125
125 % 10 = 5
So 102879-42-5 is a valid CAS Registry Number.
InChI:InChI=1/C9H11NO2.ClH/c10-6-5-7-3-1-2-4-8(7)9(11)12;/h1-4H,5-6,10H2,(H,11,12);1H
102879-42-5Relevant articles and documents
1,2,4-Triazole-3-Thione Analogues with a 2-Ethylbenzoic Acid at Position 4 as VIM-type Metallo-β-Lactamase Inhibitors
Verdirosa, Federica,Gavara, Laurent,Sevaille, Laurent,Tassone, Giusy,Corsica, Giuseppina,Legru, Alice,Feller, Georges,Chelini, Giulia,Mercuri, Paola Sandra,Tanfoni, Silvia,Sannio, Filomena,Benvenuti, Manuela,Cerboni, Giulia,De Luca, Filomena,Bouajila, Ezeddine,Vo Hoang, Yen,Licznar-Fajardo, Patricia,Galleni, Moreno,Pozzi, Cecilia,Mangani, Stefano,Docquier, Jean-Denis,Hernandez, Jean-Fran?ois
supporting information, (2022/02/16)
Metallo-β-lactamases (MBLs) are increasingly involved as a major mechanism of resistance to carbapenems in relevant opportunistic Gram-negative pathogens. Unfortunately, clinically efficient MBL inhibitors still represent an unmet medical need. We previou
